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Background:  Data on outcomes among patients with heart failure with preserved ejection fraction (HFPEF) come largely from 
administrative databases of hospitalized patients. Limited evidence exists on stable HFPEF patients.
methods:  We evaluated mortality, hospitalization rates (both all-cause and individually adjudicated as HF-related, cardiovascular [CV], 
and non-CV), and composite endpoints at 1 and 2 years in 272 consecutive outpatients with HFPEF, defined as symptoms and signs 
of HF accompanied by treatment including a diuretic, current EF >=40%, no previous record of EF <40%, and diastolic dysfunction on 
echocardiography.
results:  Baseline characteristics are presented in Table 1. After a prespecified 2-year follow up, 28 patients (10.3%) died and an 
additional 130 (47.8%) were hospitalized. There were 397 hospital admissions; 122 (30.7%) for HF, 60 (15.1%) for other CV causes, and 
215 (54.2%) for non-CV causes or elective. Hospitalization rates per 100 patient-years were 25 (95% CI: 18-32) for HF, 12 (95% CI: 8-16) 
for other CV causes, 37 (95% CI: 29-48) for all CV causes, and 81 (95% CI: 68-95) for all causes. Endpoint rates with 95% CI at 1 and 2 
years are presented in Figure 1. Results were similar when restricted to patients with EF>50% (228/272, 83.8%).
conclusion:  In contrast to hospitalized HFPEF patients, event rates are low among HFPEF outpatients and most hospitalizations are not 
related to HF. These findings have important implications for the design of HFPEF clinical trials.
